1. Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles

   Koopman, B., van der Wekken, A. J., Elst, ter, A., Hiltermann, J., Vilacha, J. F., Groves, M., van den Berg, A., Hiddinga, B., Hijmering-Kappelle, L., Stigt, J. A., Timens, W., Groen, H. J. M., Schuuring, E. & Kempen, van, L., 23-Apr-2020, In : JCO Precision Oncology. 4, p. 393-410 18 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. PD-L1 expression, CD8 cells and MHC-class-1 Beta-2-microglobulin expression in advanced non-small lung cancer

   Hijmering-Kappelle, L., Hiltermann, J., Hiddinga, B., van der Wekken, A., 't Hart, N., Groen, H. & Timens, W., Jul-2019, In : Cancer Research. 79, 13, 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Modeling of drug-protein interactions to support clinical decision making for therapy-resistant EGFR or ALK-positive non-small cell lung carcinoma

   Santos, J. F. V. M. R., Hiddinga, B. I., van Kempen, L. C., ter Elst, A., Hijmering, L. B., Hiltermann, T. J., Schuuring, E., Groves, M. R., Groen, H. J. & van der Wekken, A. J., Jul-2019, In : Cancer Research. 79, 13, 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. ctDNA a promising predictive marker for treatment with PD-1 inhibitors in KRAS mutated NSCLC after platinum based chemotherapy

   Hiltermann, T. J. N., Hijmering-Kappelle, L. B. M., Azpurua, M. L. A., van der Wekken, A. J., Hiddinga, B. L., Timens, W., Groen, H. J. M. & Schuuring, E., Jul-2019, In : Cancer Research. 79, 13, 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (4) »